CompletedNCT01072929
Armodafinil Treatment for depression
This study is completed in the United States. It is testing armodafinil Treatment for depression.
Multiple locations, including BirminghamBipolarity, DepressionOtherFrom 18 Years to 65 Years
Study directory
Back to overviewMental health studies with practical context.
Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.
CompletedNCT02734693
Dasotraline for ADHD
This study is completed in the United States. It is testing dasotraline for ADHD.
Multiple locations, including Newport BeachADHDOtherFrom 6 Years to 12 Years
CompletedNCT03231800
Dasotraline for ADHD
This study is completed in the United States. It is testing dasotraline for ADHD.
Multiple locations, including Newport BeachADHDOtherFrom 6 Years to 12 Years
CompletedNCT07193563
ENX-102 for anxiety
This study is completed in the United States. It is testing ENX-102 for anxiety.
Multiple locations, including PhoenixAnxietyOtherFrom 18 Years to 70 Years
CompletedNCT00309699
Flexible Doses of Extended-release (ER) Paliperidone Compared With Flexible Doses of Quetiapine and Placebo for Bipolarity
This study is completed in the United States, in Greece, in Lithuania, .... It is testing Flexible Doses of Extended-release (ER) Paliperidone Compared With Flexible Doses of Quetiapine and Placebo for Bipolarity.
Multiple locations, including CerritosBipolarityOtherFrom 18 Years to 65 Years
CompletedNCT00391222
Risperidone for Bipolarity
This study is completed in China, in Colombia, in Germany, .... It is testing risperidone for Bipolarity.
Multiple locations, including BaodingBipolarityOtherFrom 18 Years to 65 Years
CompletedNCT02969382
SEP-363856 for schizophrenia
This study is completed in the United States, in Hungary, in Romania, .... It is testing SEP-363856 for schizophrenia.
Multiple locations, including Little RockSchizophreniaOtherFrom 18 Years to 40 Years
CompletedNCT01364662
SPN-810 for ADHD
This study is completed in the United States. It is testing SPN-810 for ADHD.
Multiple locations, including DothanADHDOtherFrom 6 Years to 12 Years
CompletedNCT00531752
Two Doses of PF-03654746 for ADHD
This study is completed in the United States. It is testing Two Doses of PF-03654746 for ADHD.
Multiple locations, including LafayetteADHDOtherFrom 18 Years to 55 Years
CompletedNCT01725308
Efficacy of FK949E in Bipolarity people with Major Depressive Episodes
This study is completed in Japan. It is testing Efficacy of FK949E for depression.
Multiple locations, including AichiBipolarity, DepressionOtherFrom 20 Years to 64 Years
UnknownNCT06399523
Efficacy of VR for Bipolarity
This study has an unknown status in China. It is testing Efficacy of VR for Bipolarity.
In ShanghaiBipolarityBehavioralOver 13 Years
UnknownNCT06359899
Safety study of AK0901 in ADHD
This study has an unknown status in China. It is testing AK0901 for ADHD.
In BeijingADHDDrugA study involving a medication or substance.From 6 Years to 12 Years
Public registry coverage is progressing
HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.